4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-024051
President and CEO sold 300 shares at $15.00 ($4,500)
- President and CEO acquired 300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc1.xml…